Tolcapone
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 564 publications
Efficacy of MAO-B and COMT inhibitors on quality of life in patients with Parkinson's disease: a Bayesian network meta-analysis.
Journal: Frontiers in neurology
Published: November 24, 2025
Consensus Molecules Associated with Parkinson's Disease.
Journal: Neurology international
Published: November 20, 2025
Venlafaxine upregulates cortical catechol-O-methyltransferase expression and activity in rats and mice.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: November 05, 2025
Tolcapone Interferes With Key Pathological Features in Alzheimer's Disease.
Journal: Bioinorganic chemistry and applications
Published: August 26, 2025
The Seminal Role of the Proinflammatory Cytokine IL-1β and Its Signaling Cascade in Glioblastoma Pathogenesis and the Therapeutic Effect of Interleukin-1β Receptor Antagonist (IL-1RA) and Tolcapone.
Journal: International journal of molecular sciences
Published: June 25, 2025
Effects of COMT Suppression in a Randomized Trial on the Neural Correlates of Inhibitory Processing Among People With Alcohol Use Disorder.
Journal: Biological psychiatry. Cognitive neuroscience and neuroimaging
Published: May 07, 2025
Safety of COMT-inhibitors in parkinson's disease: a phase-IV comparative study on adverse events of Tolcapone, Entacapone and Opicapone.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: May 05, 2025
The Parkinson's Disease Drug Tolcapone and Analogues are Potent Glycomimetic Lectin Inhibitors of Pseudomonas aeruginosa LecA.
Journal: Angewandte Chemie (International ed. in English)
Published: April 22, 2025
Type A asparagine synthetase in the zoonotic Cryptosporidium parvum (CpAsnA): Biochemical features and potential as a novel therapeutic target.
Journal: International journal for parasitology. Drugs and drug resistance
Published: April 14, 2025
Prioritizing repurposable drugs for Alzheimer's disease using network-based analysis with concurrent assessment of Long QT syndrome risk.
Journal: Biotechnology reports (Amsterdam, Netherlands)
Published: April 11, 2025
Enzyme inhibitory activity of marine alkaloid aaptamines for neurodegenerative diseases: an in silico study.
Journal: Royal Society open science
Published: April 09, 2025
Differentiating the solution structures and stability of transthyretin tetramer complexed with tolcapone and tafamidis using SEC-SWAXS and NMR.
Journal: Journal of applied crystallography
Published: January 23, 2025
Last Updated: 04/28/2026